
SCEJ 57th Autumn Meeting
Sep. 14 (Mon) - 16 (Wed), 2026
Higashi-hiroshima Campus, Hiroshima University
Japanese page
A wide variety of therapeutic modalities are now available as biological drugs such as antibodies, virus vectors, nucleotides, peptides and extracellular vesicles. It is important to develop a proper downstream process for a specific biological drug. This symposium aims to understand the current situation and discuss on the future direction.
Most recent update: 2026-06-27 20:48:01
The keywords that frequently used in this topics code. | Keywords | Number | |
|---|---|---|---|
| Downstream process | 2 | ||
| Continuous chromatography | 1 | ||
| ACKN No. | Title/Author(s) | Keywords | Style |
|---|---|---|---|
| 420 | Analysis of antibody behavior in cation exchange chromatography using homology modeling | Homology modeling Cation exchange chromatography Antibody purification | O |
| 598 | [Requested talk] Development of a Sustainable Peptide Purification Process Using Continuous Chromatography | Peptide purification Continuous chromatography MCSGP | O |
| 738 | Improvement of mRNA Purification Using Dual Gradient Anion Exchange Membrane Chromatography | mRNA anion exchange membrane chromatography | O |
| 858 | [Review lecture] Manufacturing process of adeno-associated virus (AAV) vectors for gene therapy | AAV Gene Therapy Vector | O |
| 925 | [Review lecture] Impurity clearance behavior during continuous downstream process of monoclonal antibody | continuous downstream processing host cell protein SWATH-MS | O |
| 937 | Impurity removal behavior during downstream process of biologics Part I | Downstream process | O |
| 939 | Impurity removal behavior during downstream process of biologics Part 2 | Downstream process | O |
Organizing Committee of SCEJ 57th Annual Meeting (2026)
Inquiry